Patents by Inventor Kathryn Cunningham

Kathryn Cunningham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10293022
    Abstract: The inventors have identified how the assembly of the 5-HT2cR with another protein (phosphatase and tensin homologue; PTEN) controls cellular function, and have synthesized a new peptide that interrupts the 5-HT2cR:PTEN complex to result in enhanced 5-HT2cR function.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: May 21, 2019
    Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYTEM, THE UNIVERSITY OF HOUSTON SYSTEM
    Inventors: Kathryn Cunningham, Scott Gilbertson
  • Publication number: 20170209526
    Abstract: The inventors have identified how the assembly of the 5-HT2cR with another protein (phosphatase and tensin homologue; PTEN) controls cellular function, and have synthesized a new peptide that interrupts the 5-HT2cR:PTEN complex to result in enhanced 5-HT2cR function.
    Type: Application
    Filed: March 6, 2017
    Publication date: July 27, 2017
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Kathryn Cunningham, Scott Gilbertson
  • Patent number: 9611292
    Abstract: The 5-HT 2C receptor is implicated in feeding, obesity, palatable food reward, metabolic disorders, drug addiction, anxiety, stress sensitivity, and depression. Embodiments of the invention are directed to modulation of the 5-HT 2cR. Certain aspects are directed to therapies for the above referenced conditions. In certain aspects, therapeutic agents are identified that disrupt the 5-HT2cR:PTEN complex activating 5-HT2CR signaling. In certain aspects the complex is disrupted by a disrupter. The disrupter can be a peptide that displaces PTEN from the 5-HT 2cR:PTEN complex or inhibits the formation of the complex.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: April 4, 2017
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Kathryn Cunningham, Scott Gilbertson
  • Publication number: 20140235546
    Abstract: The 5-HT 2C receptor is implicated in feeding, obesity, palatable food reward, metabolic disorders, drug addiction, anxiety, stress sensitivity, and depression. Embodiments of the invention are directed to modulation of the 5 -HT 2cR. Certain aspects are directed to therapies for the above referenced conditions. In certain aspects, therapeutic agents are identified that disrupt the 5-HT2cR:PTEN complex activating 5-HT2CR signaling. In certain aspects the complex is disrupted by a disrupter. The disrupter can be a peptide that displaces PTEN from the 5-HT 2cR:PTEN complex or inhibits the formation of the complex.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 21, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Kathryn Cunningham, Scott Gilbertson
  • Publication number: 20060213080
    Abstract: A flip-flop shoe comprising a base having a foot engagement body joined to the base, and having combined ribbon strips tied and adhered to the foot engagement body, and coated in a hairspray. A method of making a flip-flop shoe comprising providing a base and providing a foot engagement body and joining the foot engagement body to the base, and providing combined ribbon strips and tying the combined ribbon strips to the foot engagement body with knots, and applying an adhesive to the knots and coating the combined ribbon strips with a hairspray, and trimming the combined ribbon strips.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 28, 2006
    Inventors: Carole Sussman, Kathryn Cunningham
  • Patent number: D514284
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: February 7, 2006
    Inventors: Carole Sussman, Kathryn Cunningham